The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
View Full Paper
Ask AI
Bookmark
Share
Why the study?
Does levosimendan improve clinical and hemodynamic outcomes in patients with acute heart failure or cardiogenic shock complicating acute coronary syndrome?
Population
Patients with acute heart failure and/or cardiogenic shock complicating acute coronary syndrome.
Comparison
Levosimendan vs Adrenergic inotropes or vasopressors
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May support levosimendan preference in select ACS shock cases; leaves open confirmation by prospective RCTs.
Structured PICO
Does levosimendan improve clinical and hemodynamic outcomes in patients with acute heart failure or cardiogenic shock complicating acute coronary syndrome?
P
Population
A review and expert consensus opinion on the use of levosimendan in patients with acute heart failure and cardiogenic shock complicating acute coronary syndrome.
I
Intervention
Levosimendan (used alone or in combination with other inotropic or vasopressor agents)
C
Comparator
Adrenergic inotropes or vasopressors
An expert consensus panel recommends levosimendan as a preferred inodilator for acute heart failure complicating ACS, particularly in patients on beta-blockers, due to its favorable hemodynamic and cardioprotective profile.
Limitations
- Paucity of randomized data on the management of patients with heart failure complicating acute coronary syndrome.
- Existing studies on levosimendan in acute heart failure and cardiogenic shock are not adequately powered for reaching conclusions on survival.
Cite This Study
Nieminen et al. (2016) conducted a review in Acute heart failure and cardiogenic shock complicating acute coronary syndrome. Levosimendan was evaluated. Levosimendan offers potential benefits in treating acute heart failure and cardiogenic shock complicating acute coronary syndrome and should be preferred over adrenergic inotropes as a first-line therapy in specific patients.
Topics
View Full Paper
Ask AI
Bookmark
Share